- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Remus Pharmaceuticals Ltd (REMP)
Remus Pharmaceuticals Ltd stock price live, this page displays NSE REMP stock exchange data. View the REMP premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Remus Pharmaceuticals Ltd real time stock price chart below.
What Is the Remus Pharmaceuticals Ltd Stock Price Today?
The Remus Pharmaceuticals Ltd stock price today is 928.65.
What Is the Stock Symbol for Remus Pharmaceuticals Ltd?
The stock symbol for Remus Pharmaceuticals Ltd is ""REMP.""
What Stock Exchange Does Remus Pharmaceuticals Ltd Trade On?
Remus Pharmaceuticals Ltd is listed and trades on the NSE stock exchange.
Is Remus Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether Remus Pharmaceuticals Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the REMP quote. (ISIN: INE0O5T01011)
What Is the Remus Pharmaceuticals Ltd Stock Price Today?
The Remus Pharmaceuticals Ltd stock price today is 928.65.
What Is the Stock Symbol for Remus Pharmaceuticals Ltd?
The stock symbol for Remus Pharmaceuticals Ltd is ""REMP.""
What Stock Exchange Does Remus Pharmaceuticals Ltd Trade On?
Remus Pharmaceuticals Ltd is listed and trades on the NSE stock exchange.
Is Remus Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether Remus Pharmaceuticals Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the REMP quote. (ISIN: INE0O5T01011)
NSE
Currency in INR
928.65
-10.30(-1.10%)
Closed·
Fair Value
An estimate of a Remus Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
920.00
935.00
52 wk Range
819.00
1,417.38
REMP Scorecard
Full Analysis
Trading at a low P/E ratio relative to near-term earnings growth
REMP is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Remus Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
920.00935.00
52 wk Range
819.001,417.38
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.11%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.11%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
REMP Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Remus Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy
Remus Pharmaceuticals Ltd Company Profile
Remus Pharmaceuticals Limited engages in the marketing, trading, and distribution of pharmaceutical finished formulations and products in India and internationally. It is involved in trading of active pharmaceutical ingredient, as well as provides technical consultancy services to various distributors and contract manufacturing services. The company offers capsule, cream, eye drop, gel, infusion, inhalation, inhaler, injection, nail lacquer, nasal solution, nasal spray, nebulizer, ointment, ophthalmic, oral gel, oral solution, oral suspension, sachet, suspension, and tablets. It has operations in Bhutan, Bolivia, Chile, Costa Rica, Cuba, the Dominican Republic, Ecuador, El Salvador, Guatemala, Honduras, Jamaica, Kuwait, Madagascar, Malaysia, Hong Kong, Myanmar, Panama, Trinidad and Tobago, Uzbekistan, Venezuela, and Vietnam. The company was formerly known as Remus Pharmaceuticals Private Limited and changed its name to Remus Pharmaceuticals Limited in January 2023. Remus Pharmaceuticals Limited was incorporated in 2015 and is based in Ahmedabad, India.
Compare REMP to Peers and Sector
Metrics to compare | REMP | Peers Peers - average of corresponding metrics from companies closely matching REMP: 542934, LALPATHLAB, ASTERDM, MAITREYA, KRSNAA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipREMPPeersSector |
|---|---|---|---|---|
P/E Ratio | 37.6x | 42.5x | −0.5x | |
PEG Ratio | 0.53 | 0.16 | 0.00 | |
Price/Book | 4.3x | 4.8x | 2.6x | |
Price / LTM Sales | 1.8x | 3.0x | 3.3x | |
Upside (Analyst Target) | - | 22.8% | 38.7% | |
Fair Value Upside | Unlock | −0.5% | 5.0% | Unlock |
Earnings
Latest Release
May 17, 2025
EPS / Forecast
24.90 / --
Revenue / Forecast
3.48B / --
People Also Watch
FAQ
What Stock Exchange Does Remus Pharmaceuticals Trade On?
Remus Pharmaceuticals is listed and trades on the India National Stock Exchange stock exchange.
What Is the Stock Symbol for Remus Pharmaceuticals?
The stock symbol for Remus Pharmaceuticals is "REMP."
What Is the Remus Pharmaceuticals Market Cap?
As of today, Remus Pharmaceuticals market cap is 10.41B.
What Is Remus Pharmaceuticals's Earnings Per Share (TTM)?
The Remus Pharmaceuticals EPS (TTM) is 32.61.
From a Technical Analysis Perspective, Is REMP a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has Remus Pharmaceuticals Stock Split?
Remus Pharmaceuticals has split 2 times.
How Many Employees Does Remus Pharmaceuticals Have?
Remus Pharmaceuticals has 0 employees.
What is the current trading status of Remus Pharmaceuticals (REMP)?
As of 27 Aug 2025, Remus Pharmaceuticals (REMP) is trading at a price of 928.65, with a previous close of 938.95. The stock has fluctuated within a day range of 920.00 to 935.00, while its 52-week range spans from 819.00 to 1,417.38.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.